Table 3.
HRs and 95% CIs for Individual Cardiovascular Events During 10 Years of Follow‐Up by Classification of HCM
| Classification | Model 1 | Model 2 | ||
|---|---|---|---|---|
| HR (95% CI) | P Value | HR (95% CI) | P Value | |
| Atrial fibrillation | ||||
| Labile HCM | 1 | 1 | ||
| Nonobstructive HCM | 0.90 (0.37–2.17) | 0.815 | ··· | ··· |
| Obstructive HCM | 3.43 (1.73–6.81) | <0.001 | 3.22 (1.61–6.47) | 0.001 |
| Sustained ventricular tachycardia/ventricular fibrillation | ||||
| Labile HCM | 1 | 1 | ||
| Nonobstructive HCM | 4.64 (1.56–13.82) | 0.006 | 4.69 (1.57–13.97) | 0.006 |
| Obstructive HCM | 1.89 (0.55–6.46) | 0.310 | ··· | ··· |
| Heart failure | ||||
| Labile HCM | 1 | 1 | ||
| Nonobstructive HCM | 1.97 (0.87–4.47) | 0.103 | ··· | ··· |
| Obstructive HCM | 2.10 (0.94–4.71) | 0.072 | ··· | ··· |
| All‐cause death | ||||
| Labile HCM | 1 | 1 | ||
| Nonobstructive HCM | 1.89 (0.63–5.66) | 0.254 | ··· | ··· |
| Obstructive HCM | 235 (0.82–6.78) | 0.113 | ··· | ··· |
The labile HCM was set as a reference group. Model 1, crude ratio; and model 2, adjusted for age and sex. CI indicates confidence interval; HCM, hypertrophic cardiomyopathy; and HR, hazard ratio.